Alembic announces USFDA final approval for Travoprost Ophthalmic Solution USP, 0.004%
Travoprost ophthalmic solution is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension
Travoprost ophthalmic solution is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular hypertension
The update promises to revolutionize laboratory workflows by optimizing resources
This agreement will enhance Lupin’s gastroenterology portfolio and expand its presence in emerging markets
The trial met its primary endpoint, demonstrating a statistically significant and clinically meaningful improvement in progression-free survival
The NP resin portfolio, indicated by its UL746G-certified prefix, equips manufacturers across industries to meet increasingly stringent regulatory and performance standards
The state-of-the-art facility is expected to be commissioned over the next three years
Dr Kinha is a seasoned healthcare and diagnostics leader with over 17 years of experience across leading organisations in the diagnostics sector, with deep expertise in laboratory operations and quality systems
This recognition demonstrate excellence in intellectual property (IP) value creation.
The receipt of this permission paves way for the marketing of Datopotamab Deruxtecan powder for concentrate for solution for infusion 100 mg (r-DNA origin) in India
Subscribe To Our Newsletter & Stay Updated